Cargando…
Esters of Bendamustine Are by Far More Potent Cytotoxic Agents than the Parent Compound against Human Sarcoma and Carcinoma Cells
The alkylating agent bendamustine is approved for the treatment of hematopoietic malignancies such as non-Hodgkin lymphoma, chronic lymphocytic leukemia and multiple myeloma. As preliminary data on recently disclosed bendamustine esters suggested increased cytotoxicity, we investigated representativ...
Autores principales: | Huber, Stefan, Huettner, Johannes Philip, Hacker, Kristina, Bernhardt, Günther, König, Jörg, Buschauer, Armin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721923/ https://www.ncbi.nlm.nih.gov/pubmed/26196503 http://dx.doi.org/10.1371/journal.pone.0133743 |
Ejemplares similares
-
The Extracellular Loop 2 (ECL2) of the Human Histamine H(4) Receptor Substantially Contributes to Ligand Binding and Constitutive Activity
por: Wifling, David, et al.
Publicado: (2015) -
A split luciferase-based probe for quantitative proximal determination of Gα(q) signalling in live cells
por: Littmann, Timo, et al.
Publicado: (2018) -
Highly Potent, Stable, and Selective Dimeric Hetarylpropylguanidine-Type
Histamine H(2) Receptor Agonists†
por: Pockes, Steffen, et al.
Publicado: (2018) -
Luciferase Reporter Gene Assay on Human, Murine and Rat Histamine H(4) Receptor Orthologs: Correlations and Discrepancies between Distal and Proximal Readouts
por: Nordemann, Uwe, et al.
Publicado: (2013) -
The Neuropeptide Y Y(1) Receptor: A Diagnostic Marker? Expression in MCF-7 Breast Cancer Cells Is Down-Regulated by Antiestrogens In Vitro and in Xenografts
por: Memminger, Martin, et al.
Publicado: (2012)